Anti-inflammatory Drugs
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
482
NCT03364088
Outcome After Total Knee Arthroplasty Under General or Spinal Anesthesia
Phase: N/A
Role: Collaborator
Start: Oct 3, 2016
Completion: Dec 3, 2019
NCT06926075
Early Phase Study of Kesonotide in Participants With Solid Tumours
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 6, 2025
Completion: Oct 26, 2027
Loading map...